These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20608829)

  • 21. Intrinsically vancomycin-resistant gram-positive organisms: clinical relevance and implications for infection control.
    Nelson RR
    J Hosp Infect; 1999 Aug; 42(4):275-82. PubMed ID: 10467540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nosocomial pneumonia: de-escalation is what matters.
    Ewig S
    Lancet Infect Dis; 2011 Mar; 11(3):155-7. PubMed ID: 21256087
    [No Abstract]   [Full Text] [Related]  

  • 23. Sanosil, a more effective agent for preventing the hospital-acquired ventilator associated pneumonia.
    Yousefshahi F; Khajavi MR; Anbarafshan M; Khashayar P; Najafi A
    Int J Health Care Qual Assur; 2010; 23(6):583-90. PubMed ID: 20845824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acinetobacter infection.
    Munoz-Price LS; Weinstein RA
    N Engl J Med; 2008 Mar; 358(12):1271-81. PubMed ID: 18354105
    [No Abstract]   [Full Text] [Related]  

  • 25. Vancomycin-resistant enterococci: implications for infection control.
    Molyneux R; Chadwick C
    Prof Nurse; 1997 Jun; 12(9):641-4. PubMed ID: 9248438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance movement.
    Beaumont G
    Nurs Times; 1998 Sep 16-22; 94(37):69, 72, 75. PubMed ID: 9832796
    [No Abstract]   [Full Text] [Related]  

  • 27. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia.
    Weber DJ; Rutala WA; Sickbert-Bennett EE; Samsa GP; Brown V; Niederman MS
    Infect Control Hosp Epidemiol; 2007 Jul; 28(7):825-31. PubMed ID: 17564985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical impact of multiresistant gram-positive microorganisms in long-term care facilities.
    Raz R
    J Am Med Dir Assoc; 2003; 4(3 Suppl):S100-4. PubMed ID: 12854981
    [No Abstract]   [Full Text] [Related]  

  • 29. Oral mucosal decontamination with chlorhexidine for the prevention of ventilator-associated pneumonia in children - a randomized, controlled trial.
    Sebastian MR; Lodha R; Kapil A; Kabra SK
    Pediatr Crit Care Med; 2012 Sep; 13(5):e305-10. PubMed ID: 22760426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Less ventilator-associated pneumonia after oral decontamination with chlorhexidine; a randomised trial].
    Koeman M; van der Ven AJ; Hak E; Joore JC; Kaasjager HA; de Smet AM; Ramsay G; Dormans TP; Aarts LP; de Bel EE; Hustinx WN; van der Tweel I; Hoepelman IM; Bonten MJ
    Ned Tijdschr Geneeskd; 2008 Mar; 152(13):752-9. PubMed ID: 18461894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chlorhexidine bathing and other infection control practices on the Benefits of Universal Glove and Gown (BUGG) trial: a subgroup analysis.
    Morgan DJ; Pineles L; Shardell M; Sulis C; Kett DH; Bowling J; Belton BM; Harris AD;
    Infect Control Hosp Epidemiol; 2015 Jun; 36(6):734-7. PubMed ID: 25707404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hospital-acquired infections and thermally injured patients: chlorhexidine gluconate baths work.
    Popp JA; Layon AJ; Nappo R; Richards WT; Mozingo DW
    Am J Infect Control; 2014 Feb; 42(2):129-32. PubMed ID: 24485370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities.
    Marchaim D; Chopra T; Bogan C; Bheemreddy S; Sengstock D; Jagarlamudi R; Malani A; Lemanek L; Moshos J; Lephart PR; Ku K; Hasan A; Lee J; Khandker N; Blunden C; Geffert SF; Moody M; Hiro R; Wang Y; Ahmad F; Mohammadi T; Faruque O; Patel D; Pogue JM; Hayakawa K; Dhar S; Kaye KS
    Am J Infect Control; 2012 Oct; 40(8):760-5. PubMed ID: 22285709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection control can help keep VRE in check.
    Steele T
    Nephrol News Issues; 1999 May; 13(5):37. PubMed ID: 10578822
    [No Abstract]   [Full Text] [Related]  

  • 35. Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia.
    Pfaller MA; Mendes RE; Sader HS; Jones RN
    J Antimicrob Chemother; 2010 Nov; 65(11):2396-404. PubMed ID: 20846936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical chlorhexidine and ventilator-associated pneumonia.
    Silvestri L; van Saene JJ; van Saene HK; Weir I
    Crit Care Med; 2007 Oct; 35(10):2468. PubMed ID: 17885406
    [No Abstract]   [Full Text] [Related]  

  • 37. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability.
    Montecalvo MA; McKenna D; Yarrish R; Mack L; Maguire G; Haas J; DeLorenzo L; Dellarocco N; Savatteri B; Rosenthal A; Watson A; Spicehandler D; Shi Q; Visintainer P; Wormser GP
    Am J Med; 2012 May; 125(5):505-11. PubMed ID: 22482848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of the impact of open and closed infusion systems on rates of central venous catheter-associated bacteremia.
    Rosenthal VD; Maki DG
    Am J Infect Control; 2004 May; 32(3):135-41. PubMed ID: 15153924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bloodstream infection: an ounce of prevention is a ton of work.
    Safdar N
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):511-4. PubMed ID: 16018424
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of catheter-associated urinary tract infection bundle on other health care-associated infections.
    Cheng WY; Lin YH; Lai CC; Chao CM
    Am J Infect Control; 2015 Feb; 43(2):197-8. PubMed ID: 25480446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.